Trial Profile
Open label, single dose study of Amenamevir assessing safety, tolerability and pharmacokinetics in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Dec 2018
Price :
$35
*
At a glance
- Drugs Amenamevir (Primary)
- Indications Herpes simplex virus infections; Herpes zoster
- Focus Adverse reactions; Pharmacokinetics
- 03 Dec 2018 New trial record